1. World Health Organization. Ageing and life course: interesting facts about ageing. Geneva: WHO; 2012. Online at http://www.who.int/ageing/about/facts/en/index.html# . Accessed 19 Jan 2016.
2. Australian Government: The Treasury. Intergenerational report 2010. Australia to 2050: future challenges. Barton: Treasurury of the Commonwealth of Australia; 2010. Online at http://archive.treasury.gov.au/igr/igr2010/report/html/00_Preliminaries.asp . Accessed 19 Jan 2016.
3. Pillans P. Elderly patients and polypharmacy. NPS News. 2000;13
4. Kouladjian L, Hilmer SN, Chen TF, Le Couteur DG, Gnjidic D. Assessing the harms of polypharmacy requires careful interpretation and consistent definitions. Br J Clin Pharmacol. 2014;78(3):670–1.
5. Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, McLachlan AJ, Cumming RG, Handelsman DJ, Le Couteur DG. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. Br J Clin Pharmacol. 2012;65:989–95.